Abstract
Genetic studies of bone mineral density (BMD) largely have been conducted in European populations. We therefore conducted a meta-analysis of six independent African ancestry cohorts to determine whether previously reported BMD loci identified in European populations were transferable to African ancestry populations. We included nearly 5000 individuals with both genetic data and assessments of BMD. Genotype imputation was conducted using the 1000G reference panel. We assessed single-nucleotide polymorphism (SNP) associations with femoral neck and lumbar spine BMD in each cohort separately, then combined results in fixed effects (or random effects if study heterogeneity was high, I2 index >60) inverse variance weighted meta-analyses. In secondary analyses, we conducted locus-based analyses of rare variants using SKAT-O. Mean age ranged from 12 to 68 years. One cohort included only men and another cohort included only women; the proportion of women in the other four cohorts ranged from 52% to 63%. Of 56 BMD loci tested, one locus, 6q25 (C6orf97, p = 8.87 × 10−4), was associated with lumbar spine BMD and two loci, 7q21 (SLC25A13, p = 2.84 × 10−4) and 7q31 (WNT16, p = 2.96 × 10−5), were associated with femoral neck BMD. Effects were in the same direction as previously reported in European ancestry studies and met a Bonferroni-adjusted p value threshold, the criteria for transferability to African ancestry populations. We also found associations that met locus-specific Bonferroni-adjusted p value thresholds in 11q13 (LRP5, p < 2.23 × 10−4), 11q14 (DCDC5, p < 5.35 × 10−5), and 17p13 (SMG6, p < 6.78 × 10−5) that were not tagged by European ancestry index SNPs. Rare single-nucleotide variants in AKAP11 (p = 2.32 × 10−2), MBL2 (p = 4.09 × 10−2), MEPE (p = 3.15 × 10−2), SLC25A13 (p = 3.03 × 10−2), STARD3NL (p = 3.35 × 10−2), and TNFRSF11A (p = 3.18 × 10−3) were also associated with BMD. The majority of known BMD loci were not transferable. Larger genetic studies of BMD in African ancestry populations will be needed to overcome limitations in statistical power and to identify both other loci that are transferable across populations and novel population-specific variants.
Original language | English |
---|---|
Pages (from-to) | 469-479 |
Number of pages | 11 |
Journal | Journal of Bone and Mineral Research |
Volume | 36 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2021 |
Bibliographical note
Publisher Copyright:© 2020 American Society for Bone and Mineral Research (ASBMR)
Funding
Funding sources include NIAMS R01-AR041398, 5-P60-AR30701, R01-AR049747, R01-AR051124, 5-P60-AR49465, and 5-P60-AR062760; NIA T32-AG023480 and R01-AG033618; CDC/ASPPH S043, S1734, and S3486; CDC U01DP003206 and U01DP006266; and Algynomics, Inc. The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services through contracts HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, and HHSN268201600004C. This manuscript was prepared in collaboration with investigators of the WHI and has been reviewed and approved by the Women's Health Initiative (WHI). WHI investigators are listed at http://www.whiscience.org/publications/WHI_investigators_shortlist.pdf. Authors' roles: Study design: MSY, YH, CTL, DK, and DPK. Study conduct: All. Data collection: BSZ, SFAG, JMJ, RDJ, MKE, TBH, JMZ, and DPK. Data analysis: MSY, ALK, RP, AN, SMT, SKH, LA, and AC. Data interpretation: All. Drafting manuscript: MSY. Revising manuscript content: All. Approving final version of manuscript: All. MSY takes responsibility for the integrity of the data analysis. Author Contributions: MSY: Formal analysis; investigation; methodology; writing-original draft; writing-review and editing. ALK: Formal analysis; investigation; writing-review and editing. RP: Formal analysis; investigation; writing-review and editing. AN: Formal analysis; investigation; writing-review and editing. SMT: Formal analysis; investigation; writing-review and editing. SKH: Formal analysis; investigation; writing-review and editing. LA: Formal analysis; investigation; writing-review and editing. AC: Formal analysis; investigation; writing-review and editing. YH: Investigation; methodology; writing-review and editing. CTL: Investigation; methodology; writing-review and editing. DK: Investigation; methodology; writing-review and editing. BSZ: Funding acquisition; investigation; supervision; writing-review and editing. SFAG: Funding acquisition; investigation; supervision; writing-review and editing. JMJ: Funding acquisition; investigation; supervision; writing-review and editing. RDJ: Funding acquisition; investigation; supervision; writing-review and editing. MKE: Funding acquisition; investigation; supervision; writing-review and editing. TBH: Funding acquisition; investigation; supervision; writing-review and editing. JMZ: Conceptualization; funding acquisition; investigation; methodology; supervision; writing-review and editing. DK: Conceptualization; funding acquisition; investigation; methodology; supervision; writing-review and editing. Funding sources include NIAMS R01‐AR041398, 5‐P60‐AR30701, R01‐AR049747, R01‐AR051124, 5‐P60‐AR49465, and 5‐P60‐AR062760; NIA T32‐AG023480 and R01‐AG033618; CDC/ASPPH S043, S1734, and S3486; CDC U01DP003206 and U01DP006266; and Algynomics, Inc. The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services through contracts HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, and HHSN268201600004C.
Funders | Funder number |
---|---|
Algynomics, Inc. | |
US Department of Health and Human Services | |
National Institutes of Health | |
U.S. Department of Health and Human Services | HHSN268201600002C, HHSN268201600003C, HHSN268201600001C, HHSN268201600018C, HHSN268201600004C |
National Institute on Aging | CDC/ASPPH S043, S1734, U01DP003206, U01DP006266, R01-AG033618, T32-AG023480, S3486 |
National Heart, Lung, and Blood Institute | R01HL105756 |
National Institute of Arthritis and Musculoskeletal and Skin Diseases | 5-P60-AR49465, 5-P60-AR062760, R01-AR041398, R01-AR051124, R01-AR049747, 5-P60-AR30701 |
Keywords
- AFRICAN ANCESTRY POPULATION
- BMD
- DXA
- GENERAL POPULATION STUDIES
- GENETICS
- GENETICS RESEARCH
- HUMAN ASSOCIATION STUDIES
- META-ANALYSIS
- OSTEOPOROSIS